How Automation Can Augment Drug Discovery Research
Martin-Immanuel Bittner, CEO and co-founder of Arctoris, discusses the benefits and challenges of introducing automation in drug discovery efforts.
Powered by WPeMatico
- Wabtec believes full automation for railroads is within reach
- Public beta for Autodesk Tandem digital twin platform